Evidence map›Paper›PMID 29129473›Full record

ArticleJournal of autoimmunity2018

Dominant-negative loss of function arises from a second, more frequent variant within the SAND domain of autoimmune regulator (AIRE).

Jordan K Abbott, Yu-San Huoh, Paul R Reynolds, Liping Yu, Marian Rewers, Monica Reddy, Mark S Anderson, Sun Hur, Erwin W Gelfand

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of autoimmunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Systematic and proactive evaluation of AIRE missense variant effects.bioRxiv : the preprint server for biology · 2025
    Article
  4. A novel heterozygous pathogenicJournal of human immunity · 2025
    Article
  5. Review
  6. Aire Mutations and Autoimmune Diseases.Advances in experimental medicine and biology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jordan K AbbottNational Jewish Health, Immunodeficiency Diagnosis and Treatment Program, Department of Pediatrics, 1400 Jackson Street, Denver, CO, 80206, USA. Electronic address: abbottj@njhealth.org.
Yu-San HuohBoston Children's Hospital, Program in Cellular and Molecular Medicine, 3 Blackfan Circle, Boston, MA, 02115, USA. Electronic address: san.huoh@childrens.harvard.edu.
Paul R ReynoldsNational Jewish Health, Immunodeficiency Diagnosis and Treatment Program, Department of Pediatrics, 1400 Jackson Street, Denver, CO, 80206, USA. Electronic address: reynoldsp@njhealth.org.
Liping YuBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, 1775 Aurora Court, Aurora, CO, 80045, USA. Electronic address: liping.yu@ucdenver.edu.
Marian RewersBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, 1775 Aurora Court, Aurora, CO, 80045, USA. Electronic address: Marian.Rewers@ucdenver.edu.
Monica ReddyColorado Allergy & Asthma Centers, P.C., 125 Rampart Way, Ste 100, Denver, CO, 80601, USA. Electronic address: monica.b.reddy@gmail.com.
Mark S AndersonUCSF Diabetes Center, UCSF School of Medicine, 513 Parnassus Ave., San Francisco, CA, 94143, USA. Electronic address: Mark.Anderson@ucsf.edu.
Sun HurBoston Children's Hospital, Program in Cellular and Molecular Medicine, 3 Blackfan Circle, Boston, MA, 02115, USA. Electronic address: sun.hur@childrens.harvard.edu.
Erwin W GelfandNational Jewish Health, Immunodeficiency Diagnosis and Treatment Program, Department of Pediatrics, 1400 Jackson Street, Denver, CO, 80206, USA. Electronic address: gelfande@njhealth.org.
National Jewish Health · USBoston Children's Hospital · USUniversity of Colorado Denver · USAllergy, Asthma and Clinical Research Center · USUniversity of California San Francisco Medical Center · US

Funding

MOLECULAR BASIS OF ALLERGIC AND IMMUNOLOGIC DISEASET32AI007512 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI Janet Chou, Peter A Nigrovic · 1996 to 2026
$13.1M
Thymic medullary epithelial cell turnover and control of immune toleranceR37AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark S Anderson · 2017 to 2026
$4.0M
Molecular Mechanisms for Antiviral Signal Activation by MDA5 and RIG-IR01AI106912 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUR, SUN · 2014 to 2018
$2.2M
Thymic medullary epithelial cell turnover and control of immune toleranceR01AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 2012 to 2016
$1.9M
NIAID NIH HHS R01 AI097457NIAID NIH HHS R01 AI106912NIAID NIH HHS R37 AI097457NIAID NIH HHS T32 AI007512
6 · The paper itself

Abstract

A genetic variant in the SAND domain of autoimmune regulator (AIRE), R247C, was identified in a patient with type I diabetes mellitus (T1DM) and his mother with rheumatoid arthritis. In vitro, the variant dominantly inhibited AIRE; however, typical features of Autoimmune Polyendocrinopathy Candidiasis and Ectodermal Dysplasia (APECED) were not seen in the subjects. Rather, early manifestation of autoimmunity appeared to be dependent on additional genetic factors. On a population level, diverse variants were identified in this region. Surprisingly, many likely pathogenic variants were seen disproportionately in Africans when compared to Europeans, reinforcing the importance of these variants in altering the immune repertoire. In light of these findings, we propose that R247C and other variants within the SAND-domain alter protein function in a dominant fashion and hold potential as drivers of autoimmunity.

Indexed as

AdolescentAIRE ProteinAutoimmunityBlack PeopleChild, PreschoolDiabetes Mellitus, Type 1HEK293 CellsHumansLoss of Function MutationMalePedigreePolyendocrinopathies, AutoimmunePolymorphism, GeneticProtein DomainsTranscription FactorsWhite PeopleAIRE ProteinTranscription FactorsAutoimmune regulatorDominant-negative mutationImmune toleranceNext generation sequencingType I diabetes mellitus

Identifiers

PMID29129473
PMCPMC5846191
OpenAlexW2767948581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.